The short version of Copper peptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-19. Anything still debated is marked as such rather than presented as settled.
Published work on GHK-Cu is dominated by in vitro experiments and small animal studies. Human trials tend to be short and small, with endpoints such as skin appearance rather than clinical outcomes. Review articles often summarize the same underlying laboratory findings, which can make the evidence base look broader than it is. Several basic questions remain open: the concentration of the intact complex in human tissue, the route by which it crosses the skin barrier, and whether effects seen in culture produce measurable changes in people.
Laboratory studies describe GHK-Cu as a source of copper that cells can take up, with reported effects on collagen, elastin, and glycosaminoglycan synthesis in cultured fibroblasts. The peptide also appears in wound-repair research, where it is linked to the activity of matrix metalloproteinases and their inhibitors. These observations come largely from cell and animal models. How directly the complex controls any single pathway in intact human skin remains an open question, and reported effects depend on concentration, vehicle, and exposure time.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.
Copper(II) binds the peptide through four nitrogen donors: the terminal amino group, the imidazole nitrogen of histidine, and two deprotonated amide nitrogens of the peptide backbone. This tetradentate arrangement gives a roughly square-planar geometry, the thermodynamically favoured form near neutral pH. Because the amide nitrogens must lose a proton before they can coordinate, complex formation is strongly pH-dependent, and the fully coordinated species dominates only above mildly acidic conditions. Electronic transitions within the copper d orbital set produce the characteristic blue to violet colour in aqueous solution.
Endogenous GHK occurs in blood plasma, saliva, and urine, and reported plasma concentrations decline with age in several studies. Researchers have proposed that the peptide acts as a copper carrier that delivers the metal to cells and to sites of injury. That transport role is a hypothesis supported by binding measurements and tissue-distribution data rather than a settled mechanism, and the peptide is generally described as a minor contributor to total plasma copper transport. Values reported in wound fluid and certain tissue extracts are higher than in circulating plasma.
| Property | Value | Notes |
|---|---|---|
| Copper binding sites | Imidazole, amino, and amide nitrogens | Form chelate rings with Cu(II) |
| Conditional binding constant | Reported near 10^16 at neutral pH | Value depends on method and medium |
| Visible absorption | Broad band in the blue-violet region | Source of the characteristic color |
| Common analytical methods | LC-MS, HPLC, UV-Vis, ICP-OES | Used for identity and copper content |
| Main degradation routes | Oxidation, photolysis, hydrolysis | Accelerated by light, heat, and pH extremes |
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
Material described in research and cosmetic supply chains is typically a synthetic peptide supplied as a lyophilized powder. Purity is commonly reported through chromatographic separation, often at 95 percent or higher, while copper content is confirmed by separate elemental analysis. Batch variation in color and solubility can reflect residual counter-ions, moisture, or partial oxidation of the peptide. Because the complex is not a single regulatory entity, specifications differ between suppliers and are not standardized internationally.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
The peptide sequence places a histidine in the middle, and this residue dominates metal binding. Copper(II) coordinates through the imidazole nitrogen of histidine and the terminal amino group, forming a stable chelate ring system. Loss of the copper ion leaves the free tripeptide, which has different solubility and reactivity. This structural detail matters because assays that measure only the peptide backbone can miss whether copper is still bound to it.
=== Diagnostics === As anti-angiogenic cancer therapies have achieved widespread use, there has been increased interest in non-invasive monitoring of angiogenesis. One of the most extensively examined targets of angiogenesis is integrin αVβ3. Radiolabeled peptides containing RGD show high affinity and selectivity for integrin αVβ3 and are being investigated as tools to monitor treatment response of tumors via PET imaging. These include 18F-Galacto-RGD, 18F-Fluciclatide-RGD, 18F-RGD-K5, 68Ga-NOTA-RGD, 68Ga-NOTA-PRGD2, 18F-Alfatide, 18F-Alfatide II, and 18F-FPPRGD2. In a meta-analysis of studies using PET/CT in patients with cancer, it was shown that this diagnostic method may be very useful for detecting malignancies and predicting short-term outcomes, although larger-scale studies are needed.
The city's automotive industry played a pivotal role in the Italian economic miracle of the 1950s and 1960s, attracting hundreds of thousands of migrants to the city, particularly from the rural southern regions of Italy. The number of migrants was so high that Turin was said to be "the third southern Italian city after Naples and Palermo". The population soon reached 1 million in 1960 and peaked at almost 1.2 million in 1971. The exceptional growth gains of the city gained it the nickname of Capitale dell'automobile (Automobile Capital), being often compared with Detroit, the major centre of the U.S. automobile industry (these cities were 'twinned' as sister cities in 1998). In the 1970s and 1980s, the oil and automotive industry crisis severely hit the city, and its population began to sharply decline as jobs were lost. In 30 years, the population decreased by more than one-fourth of the 1971 total. The long population decline of the city has begun to reverse itself only in recent years; the population grew from 865,000 to slightly over 900,000 by the end of the 20th century. In 2006, Turin hosted the Winter Olympic Games.
== Series 2 == The 28-episode series 2 covers volumes 3 to 5 of the original novels. Reinhard von Lohengramm achieves almost all his goals: the Goldenbaum dynasty is finally overthrown and the Free Planets Alliance is defeated and occupied. One of the main themes is the comparison between a corrupt democracy and an efficient dictatorship and the moral issues of such a situation, with Yang Wen-li standing for democracy because a corrupt democracy can be amended, while a dictatorship can only be overthrown by force, and a wise dictator is an exception.
=== Animal models === Fetomaternal microchimerism has been shown in experimental investigations of whether fetal cells can cross the blood brain barrier in mice. The properties of these cells allow them to cross the blood brain barrier and target injured brain tissue. This mechanism is possible because umbilical cord blood cells express some proteins similar to neurons. When these umbilical cord blood cells are injected in rats with brain injury or stroke, they enter the brain and express certain nerve cell markers. Due to this process, fetal cells could enter the brain during pregnancy and become differentiated into neural cells. Fetal microchimerism can occur in the maternal mouse brain, responding to certain cues in the maternal body.
Sources: en.wikipedia.org
The American chocolate maker Hershey's purchased the Aero patent the following May, later altering the flavour and texture for the American palate. During 1937, Rowntree's produced machinery for production in Ireland, Canada and South Africa, as well as for the companies Lindt and Van Houten.
Clifford insisted that no British troops should be committed for the suppression of the rebellion. In October, Clarke arrived at Wepener at the head of a force of 1,000 cavalry, 600 infantry, five artillery pieces, and 40 wagons. Clarke was aiming to relieve Mafeteng, whose garrison was forced to exchange messages written in Greek, since some Basuto chiefs spoke both English and French. Clarke's advance was slowed by deep mud, and the Basuto cavalry regularly harried the column with rifle fire before withdrawing. On 19 October, the Cape army reached Qalabane, an isolated kop halfway between Wepener and Mafeteng. Lerotholi had positioned 3,000 of his warriors behind a ridge that overlooked a nearby road. The advanced guard of the Cape Mounted Yeomanry came under rifle fire from the kop. Clarke ordered the artillery to fire upon the kop and dispatched 200 men from the 1st Cape Mounted Yeomanry to flank the kop from the left. CMY commander Captain Dalgety ordered his soldiers to dismount and assume an open order formation. Chief Seiso's led a charge of 300 axe-wielding Basuto cavalrymen on Dalgety's unit before the latter was able to reach the crest. The 2nd CMY reinforced Dalgety soon afterwards and captured a nearby village. The Cape army lost 32 killed and seven injured, while the Basuto lost 40 killed. The yeomanry was almost defenseless in hand-to-hand combat, as it was not yet issued bayonets or swords.
sequence logo In bioinformatics, a graphical representation of the conservation of nucleobases or amino acids at each position within a nucleic acid or protein sequence. Sequence logos are created by aligning many sequences and used to depict consensus sequences as well as the degree of variability within the pool of aligned sequences.
Unlike graphene, which is a two-dimensional semimetal, carbon nanotubes are either metallic or semiconducting along the tubular axis. For a given (n,m) nanotube, if n = m, the nanotube is metallic; if n − m is a multiple of 3 and n ≠ m, then the nanotube is quasi-metallic with a very small band gap, otherwise the nanotube is a moderate semiconductor. Thus, all armchair (n = m) nanotubes are metallic, and nanotubes (6,4), (9,1), etc. are semiconducting. Carbon nanotubes are not semimetallic because the degenerate point (the point where the π [bonding] band meets the π* [anti-bonding] band, at which the energy goes to zero) is slightly shifted away from the K point in the Brillouin zone because of the curvature of the tube surface, causing hybridization between the σ* and π* anti-bonding bands, modifying the band dispersion. The rule regarding metallic versus semiconductor behavior has exceptions because curvature effects in small-diameter tubes can strongly influence electrical properties. Thus, a (5,0) SWCNT that should be semiconducting in fact is metallic according to the calculations. Likewise, zigzag and chiral SWCNTs with small diameters that should be metallic have a finite gap (armchair nanotubes remain metallic). In theory, metallic nanotubes can carry an electric current density of 4 billion A/cm2, which is more than 1,000 times greater than those of metals such as copper, where for copper interconnects, current densities are limited by electromigration.
==== Companion of the Order of the Bath (CB) ==== Military Rear Admiral Andrew Betton, , Royal Navy, C033663C. Rear Admiral James David Morley, Royal Navy, C034410Y Major General Kevin Mark Copsey, , 533047. Major General John Robert Mead, , 537468. Air Vice-Marshal Nigel James Colman, , Royal Air Force, 8304546T. Air Marshal Ian David Gale, , Royal Air Force, 8304212Q. Civil Ruth Léonie Hannant, Director General, Policy, Department for Culture, Media and Sport. For Public Service. Liam Cledwyn Laurence Smyth, Clerk of Legislation, House of Commons. For services to Parliament. Jonathan Marron, Director General, Office of Health Inequalities and Disparities, Department of Health and Social Care. For services to Public Health. Lee McDonough, Director General, Net Zero, Nuclear and International, Department for Energy Security and Net Zero. For services to Energy and Climate. Simon Millhouse, Ministry of Defence. For services to Defence. Neil Brendan O'Connor, , lately Director, Building Safety Programme, Department for Levelling Up, Housing and Communities. For services to Building Safety. Polly Theresa Payne, Director General, Policy, Department for Culture, Media and Sport. For Public Service. Sir Arthur Gareth Ludovic Emrys Rhys Williams, , Government Chief Commercial Officer, Cabinet Office. For Public Service. Kenneth Andrew Lyons Thomson, lately Director General, Scottish Government. For Public Service. Brendan Peter Threlfall, , Director General, Union and Windsor Framework, Cabinet Office. For Public Service. Dr Abigail Tierney, lately Director General, Home Office.
Sources: en.wikipedia.org
This is in part due to the myriad job titles used to describe them, including clinical physiologists, medical physicists, and clinical biochemists, which generally mean the public and other healthcare workers assume clinical scientists to be medically qualified doctors, due to the sometimes complex nature of the role.
=== Detection in body fluids === Buprenorphine and norbuprenorphine may be quantified in blood or urine to monitor use or non-medical recreational use, confirm a diagnosis of poisoning, or assist in a medicolegal investigation. A significant overlap of drug concentrations exists in body fluids within the possible spectrum of physiological reactions ranging from asymptomatic to comatose. Therefore, knowing both the route of administration of the drug and the level of tolerance to opioids of the individual is critical when results are interpreted.
Susineridine (INNTooltip International Nonproprietary Name; developmental code name YZJ-4729) is an atypical μ-opioid receptor (MOR) agonist and opioid analgesic which is under development for the treatment of postoperative pain. It is given intravenously. The drug acts as a selective biased partial agonist of the MOR, with functional selectivity for activation of G protein signaling over β-arrestin2 recruitment. Its mechanism of action and pharmacological activity are said to be similar to those of oliceridine. However, in-vitro findings suggest that susineridine may have a greater degree of G protein bias than oliceridine. The drug produces analgesic effects in multiple animal models of pain and produces less respiratory depression than morphine or oliceridine. The pharmacokinetics of susineridine in humans have been studied. Susineridine was patented and first described in the scientific literature in 2023. It is under development by Shanghai Haiyan Pharmaceutical Technology in China. As of May 2025, the drug is in phase 3 clinical trials for postoperative pain.
The metabolome is the complete set of small-molecule chemicals found within a biological sample. The biological sample can be a cell, a cellular organelle, an organ, a tissue, a tissue extract, a biofluid or an entire organism. The small molecule chemicals found in a given metabolome may include both endogenous metabolites that are naturally produced by an organism (such as amino acids, organic acids, nucleic acids, fatty acids, amines, sugars, vitamins, co-factors, pigments, antibiotics, etc.) as well as exogenous chemicals (such as drugs, environmental contaminants, food additives, toxins and other xenobiotics) that are not naturally produced by an organism. In other words, there is both an endogenous metabolome and an exogenous metabolome. The endogenous metabolome can be further subdivided to include a "primary" and a "secondary" metabolome (particularly when referring to plant or microbial metabolomes). A primary metabolite is directly involved in the normal growth, development, and reproduction. A secondary metabolite is not directly involved in those processes, but usually has important ecological function. Secondary metabolites may include pigments, antibiotics or waste products derived from partially metabolized xenobiotics. The study of the metabolome is called metabolomics.
Sources: en.wikipedia.org
It is not approved as a pharmaceutical in major markets and is used mainly as a cosmetic ingredient and a laboratory reagent. Regulatory status varies by country and by the product category in which it appears. Claims about therapeutic effects should be treated separately from permitted cosmetic labeling.
Reversed-phase high-performance liquid chromatography and mass spectrometry are common for the peptide portion. Copper content is usually determined by inductively coupled plasma techniques or by spectrophotometry. Ultraviolet-visible spectroscopy takes advantage of the visible absorption band of the copper complex.
Light, oxygen, and elevated temperature promote degradation of the peptide, and strongly acidic or alkaline conditions accelerate hydrolysis. The copper complex is generally more resistant to oxidation than the free peptide. Storage in a dry, dark, cold environment limits loss over time.
It consists of a three-amino-acid peptide, glycine-histidine-lysine, bound to one copper(II) ion. The peptide supplies four nitrogen donor atoms, and the resulting complex is stable in neutral aqueous solution. The metal-free peptide is usually called GHK.